Authors: Bellobuono, A Mondazzi, L Tempini, S Chiodo, F Magliano, E Furione, L Ideo, G

Citation: A. Bellobuono et al., Early addition of ribavirin to interferon in chronic hepatitis C not responsive to interferon monotherapy, J HEPATOL, 33(3), 2000, pp. 463-468

Authors: Ideo, G Bellobuono, A Tempini, S Mondazzi, L Airoldi, A Benetti, G Bissoli, F Cestari, C Colombo, E Del Poggio, P Fracassetti, O Lazzaroni, S Marelli, A Paris, B Prada, A Rainer, E Roffi, L

Citation: G. Ideo et al., Antioxidant drugs combined with alpha-interferon in chronic hepatitis C not responsive to alpha-interferon alone: a randomized, multicentre study, EUR J GASTR, 11(11), 1999, pp. 1203-1207

Authors: Bellobuono, A Mondazzi, L Tempini, S Chiodo, F Magliano, E Mondini, C Ideo, G

Citation: A. Bellobuono et al., Should patients with early loss of serum HCV-RNA during alpha interferon therapy for chronic hepatitis C be treated for 6 or 12 months?, J HEPATOL, 30(1), 1999, pp. 8-13

Authors: Schalm, SW Weiland, O Hansen, BE Milella, M Lai, FY Hollander, A Michielsen, PP Bellobuono, A Chemello, L Pastore, G Chen, DS Brouwer, JT

Citation: Sw. Schalm et al., Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials, GASTROENTY, 117(2), 1999, pp. 408-413